A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections

As a significant public health hazard with several drug side effects during medical treatment, searching for novel therapeutic natural medicines is promising. Sulfated polysaccharides from algae, such as fucoidan, have been discovered to have a variety of medical applications, including antibacteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Biswajita, Nayak, Rabindra, Patra, Srimanta, Bhuyan, Prajna Paramita, Behera, Pradyota Kumar, Mandal, Amiya Kumar, Behera, Chhandashree, Ki, Jang-Seu, Adhikary, Siba Prasad, MubarakAli, Davoodbasha, Jena, Mrutyunjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057937/
https://www.ncbi.nlm.nih.gov/pubmed/35698330
http://dx.doi.org/10.1016/j.carbpol.2022.119551
_version_ 1784698011780120576
author Pradhan, Biswajita
Nayak, Rabindra
Patra, Srimanta
Bhuyan, Prajna Paramita
Behera, Pradyota Kumar
Mandal, Amiya Kumar
Behera, Chhandashree
Ki, Jang-Seu
Adhikary, Siba Prasad
MubarakAli, Davoodbasha
Jena, Mrutyunjay
author_facet Pradhan, Biswajita
Nayak, Rabindra
Patra, Srimanta
Bhuyan, Prajna Paramita
Behera, Pradyota Kumar
Mandal, Amiya Kumar
Behera, Chhandashree
Ki, Jang-Seu
Adhikary, Siba Prasad
MubarakAli, Davoodbasha
Jena, Mrutyunjay
author_sort Pradhan, Biswajita
collection PubMed
description As a significant public health hazard with several drug side effects during medical treatment, searching for novel therapeutic natural medicines is promising. Sulfated polysaccharides from algae, such as fucoidan, have been discovered to have a variety of medical applications, including antibacterial and immunomodulatory properties. The review emphasized on the utilization of fucoidan as an antiviral agent against viral infections by inhibiting their attachment and replication. Moreover, it can also trigger immune response against viral infection in humans. This review suggested to be use the fucoidan for the potential protective remedy against COVID-19 and addressing the antiviral activities of sulfated polysaccharide, fucoidan derived from marine algae that could be used as an anti-COVID19 drug in near future.
format Online
Article
Text
id pubmed-9057937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90579372022-05-02 A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections Pradhan, Biswajita Nayak, Rabindra Patra, Srimanta Bhuyan, Prajna Paramita Behera, Pradyota Kumar Mandal, Amiya Kumar Behera, Chhandashree Ki, Jang-Seu Adhikary, Siba Prasad MubarakAli, Davoodbasha Jena, Mrutyunjay Carbohydr Polym Review As a significant public health hazard with several drug side effects during medical treatment, searching for novel therapeutic natural medicines is promising. Sulfated polysaccharides from algae, such as fucoidan, have been discovered to have a variety of medical applications, including antibacterial and immunomodulatory properties. The review emphasized on the utilization of fucoidan as an antiviral agent against viral infections by inhibiting their attachment and replication. Moreover, it can also trigger immune response against viral infection in humans. This review suggested to be use the fucoidan for the potential protective remedy against COVID-19 and addressing the antiviral activities of sulfated polysaccharide, fucoidan derived from marine algae that could be used as an anti-COVID19 drug in near future. Elsevier Ltd. 2022-09-01 2022-05-02 /pmc/articles/PMC9057937/ /pubmed/35698330 http://dx.doi.org/10.1016/j.carbpol.2022.119551 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Pradhan, Biswajita
Nayak, Rabindra
Patra, Srimanta
Bhuyan, Prajna Paramita
Behera, Pradyota Kumar
Mandal, Amiya Kumar
Behera, Chhandashree
Ki, Jang-Seu
Adhikary, Siba Prasad
MubarakAli, Davoodbasha
Jena, Mrutyunjay
A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title_full A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title_fullStr A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title_full_unstemmed A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title_short A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
title_sort state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057937/
https://www.ncbi.nlm.nih.gov/pubmed/35698330
http://dx.doi.org/10.1016/j.carbpol.2022.119551
work_keys_str_mv AT pradhanbiswajita astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT nayakrabindra astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT patrasrimanta astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT bhuyanprajnaparamita astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT beherapradyotakumar astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT mandalamiyakumar astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT beherachhandashree astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT kijangseu astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT adhikarysibaprasad astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT mubarakalidavoodbasha astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT jenamrutyunjay astateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT pradhanbiswajita stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT nayakrabindra stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT patrasrimanta stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT bhuyanprajnaparamita stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT beherapradyotakumar stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT mandalamiyakumar stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT beherachhandashree stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT kijangseu stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT adhikarysibaprasad stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT mubarakalidavoodbasha stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections
AT jenamrutyunjay stateoftheartreviewonfucoidanasanantiviralagenttocombatviralinfections

Ejemplares similares